Cancer Vaccine Developer Files Ch. 7 After Trials Fall Short
By Rick Archer · March 31, 2026, 1:51 PM EDT
A Denmark-based biotechnology firm filed for Chapter 7 liquidation Tuesday in Delaware with more than $10 million in debt after its prospective cancer vaccine failed to measure up under testing and...
To view the full article, register now.